The MPN Leaders Programme is a fully immersive, educational development programme aiming to support emerging haematology leaders specialising in the field of myeloproliferative neoplasms (MPN).

Designed by a steering committee of leading MPN specialists, in collaboration with Novartis, this multi-step programme presents a unique opportunity to gain experience of working in, and contributing to, the field of MPN, and to engage with renowned senior clinical leaders.

The programme focuses on the following key themes:


Icon. Loudspeaker icon

Knowledge sharing and case review

Icon. Expert icon

Expert support and guidance

Icon. Clinical data icon

Clinical data review and analysis


Icon. Data icon

Educational plenary presentations

Icon. Networking icon

Professional networking

Icon. Academic icon

MDT discussions



The MPN Leaders Programme is organised and funded by Novartis Pharmaceuticals UK Ltd and is classed as promotional under the Association of the British Pharmaceutical Industry (ABPI) Code. Prescribing information will be available throughout the programme for all Novartis brands mentioned. Participation in the programme will be funded by Novartis (delegate travel, accommodation and reasonable expenses will be covered in the event of a face-to-face meeting). The Steering Committee has been offered an honorarium for their involvement in this programme.

MDT, multidisciplinary team.

Rate this content: 
No votes yet
HCP20-C048 October 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]